Integra LifeSciences Holdings Corp. (IART)
NGS · Common · CUSIP 457985208
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IART and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
457985208
Market Cap
Large Cap
Previous Name
Integra LifeSciences Corp.
Business: Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for caregivers, so they can concentrate on providing the best patient care. Integra offers innovative solutions, including leading regenerative technologies, in specialty surgical solutions, orthopedics and tissue technologies and spine hardware and orthobiologics.
Notes: Dec. 22, 2016 -- Integra LifeSciences Holdings Corp. (NASDAQ:IART) today announced that its stockholders approved a two-for-one stock split and an increase from 60 million to 240 million authorized shares of the Company's common stock at a special meeting of stockholders. Holders of record, as of the close of markets on December 21, 2016, will be entitled to receive one additional share of common stock for each share held. The shares are expected to be distributed on January 3, 2017. The adjusted stock price is expected to be reflected on the NASDAQ stock market on January 4, 2017._______________June 9, 2015 -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Board of Directors of Integra has approved the separation of SeaSpine Holdings Corp. from Integra in the form of a tax-free dividend involving the distribution of all outstanding shares of SeaSpine common stock to holders of Integra common stock. Integra stockholders will receive one share of SeaSpine common stock for every three shares of Integra common stock held by such holders. SeaSpine common stock will be distributed on July 1, 2015 SeaSpine expects its common stock to begin trading on a when-issued basis shortly before the June 19, 2015 record date under the ticker SPNEV and will continue until the distribution occurs. SeaSpine when-issued trades will settle after July 1, 2015, with newly issued shares of SeaSpine, Ticker SPNE.

Company Contact

CEO
Jan De Witte
CFO
Glenn G. Coleman
Headquarters
311 Enterprise Drive, Plainsboro, NJ 08536
Phone
609-275-0500 · Toll-Free 800-654-2873
Fax
609-275-5363
Investor Relations
Angela Steinway · 609-936-2268 · angela.steinway@integralife.com
General Email
ir@integralife.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »